Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Antin

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
Neurology|October 24, 2001
Gliomas arising in organ transplant recipients: an unrecognized complication of transplantation?D Schiff, B O'Neill, E Wijdicks, et al.
The Journal of Clinical Investigation|August 1, 1987
B lymphocyte reconstitution after human bone marrow transplantation. Leu-1 antigen defines a distinct population of B lymphocytesJ H Antin, K A Ault, J M Rappeport, et al.
Blood|November 1, 1986
Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factorM A Goldberg, J H Antin, E C Guinan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1986
Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studiesJ H Antin, S G Emerson, P Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysisC Cutler, S Giri, S Jeyapalan, et al.
Behring Institute Mitteilungen|August 1, 1988
Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failureJ H Antin, B R Smith, W Holmes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 9, 2000
Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infectionsM J Vasconcelles, M V Bernardo, C King, et al.
Transfusion|February 26, 1999
ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantationR J Benjamin, S McGurk, M S Ralston, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 1999
Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemiaR J Benjamin, J M Connors, S McGurk, et al.
Bone Marrow Transplantation|January 2, 1997
Idiopathic thrombocytopenic purpura following allogeneic bone marrow transplantation--treatment with anti-D immunoglobulinS J Lee, W H Churchill, A Konugres, et al.
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
Neurology|October 24, 2001
Gliomas arising in organ transplant recipients: an unrecognized complication of transplantation?D Schiff, B O'Neill, E Wijdicks, et al.
The Journal of Clinical Investigation|August 1, 1987
B lymphocyte reconstitution after human bone marrow transplantation. Leu-1 antigen defines a distinct population of B lymphocytesJ H Antin, K A Ault, J M Rappeport, et al.
Blood|November 1, 1986
Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factorM A Goldberg, J H Antin, E C Guinan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1986
Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studiesJ H Antin, S G Emerson, P Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysisC Cutler, S Giri, S Jeyapalan, et al.
Behring Institute Mitteilungen|August 1, 1988
Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failureJ H Antin, B R Smith, W Holmes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 9, 2000
Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infectionsM J Vasconcelles, M V Bernardo, C King, et al.
Transfusion|February 26, 1999
ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantationR J Benjamin, S McGurk, M S Ralston, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 1999
Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemiaR J Benjamin, J M Connors, S McGurk, et al.
Bone Marrow Transplantation|January 2, 1997
Idiopathic thrombocytopenic purpura following allogeneic bone marrow transplantation--treatment with anti-D immunoglobulinS J Lee, W H Churchill, A Konugres, et al.
Pageof 12